Emmanuel Vincent, our CEO, will be attending the ISCT Annual Meeting in Dublin, Ireland, from 6 to 9 May 2026 at the Convention Centre Dublin. 

At ISCT, Aenitis will highlight its Acoustic Cell Handling platform and its Modular Type Package (MTP) approach, designed to facilitate the integration of acoustic unit operations into existing bioprocess workflows. 

A pioneer in acoustic-based cell manipulation, the company is advancing cell and gene therapy manufacturing with its non-invasive, scalable acoustofluidic technology, enabling precise, sterile, and gentle cell processing across research, clinical, and industrial applications. 

Take the opportunity to meet Emmanuel and learn how Aenitis is contributing to the evolution of scalable and GMP-ready cell therapy manufacturing. 

Lien: Home – ISCT 2026 Dublin